Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

687 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.
Shimabukuro M, Tanaka A, Sata M, Dai K, Shibata Y, Inoue Y, Ikenaga H, Kishimoto S, Ogasawara K, Takashima A, Niki T, Arasaki O, Oshiro K, Mori Y, Ishihara M, Node K; Collaborators on the Effect of Miglitol on Glucose Metabolism in Acute Coronary Syndrome (MACS) Study. Shimabukuro M, et al. Among authors: node k. Cardiovasc Diabetol. 2017 Jul 6;16(1):86. doi: 10.1186/s12933-017-0571-1. Cardiovasc Diabetol. 2017. PMID: 28683829 Free PMC article. Clinical Trial.
Flow-mediated vasodilation as a diagnostic modality for vascular failure.
Inoue T, Matsuoka H, Higashi Y, Ueda S, Sata M, Shimada KE, Ishibashi Y, Node K; Vascular Failure Workshop Group. Inoue T, et al. Among authors: node k. Hypertens Res. 2008 Dec;31(12):2105-13. doi: 10.1291/hypres.31.2105. Hypertens Res. 2008. PMID: 19139600 Review.
Effects of sitagliptin beyond glycemic control: focus on quality of life.
Sakamoto Y, Oyama J, Ikeda H, Kuroki S, Gondo S, Iwamoto T, Uchida Y, Kodama K, Hiwatashi A, Shimomura M, Taguchi I, Inoue T, Node K; S-DOG investigators. Sakamoto Y, et al. Among authors: node k. Cardiovasc Diabetol. 2013 Feb 21;12:35. doi: 10.1186/1475-2840-12-35. Cardiovasc Diabetol. 2013. PMID: 23432786 Free PMC article.
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F; EXAMINE Investigators. White WB, et al. N Engl J Med. 2013 Oct 3;369(14):1327-35. doi: 10.1056/NEJMoa1305889. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992602 Free article. Clinical Trial.
Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R, Node K, Hanafusa T, Atsumi Y, Naito Y, Oka Y. Kawamori R, et al. Among authors: node k. Cardiovasc Diabetol. 2013 Sep 8;12:131. doi: 10.1186/1475-2840-12-131. Cardiovasc Diabetol. 2013. PMID: 24011395 Free PMC article.
687 results